Quantel Medical announced the Optimis Fusion integrated laser platform received CE Mark approval. The fusion system combines advanced selective laser trabeculoplasty photoregeneration therapy and traditional YAG photodisruption treatments to offer surgeons a versatile arsenal for treating both cataract and glaucoma. Chief Executive Officer Jean-Marc Gendre explained in a company press release, “This approval constitutes a critical milestone for our medical laser business.
Help employers find you! Check out all the jobs and post your resume.
